Carl Wooten is the founder and Chief Consulting Officer of The RISE Advisory Group, where he helps life sciences leaders move forward when the opportunity is significant and the path ahead is anything but certain.
For more than 25 years, Carl has worked alongside leaders across pharmaceutical, biotechnology, healthcare and the organizations that serve them. His work connects growth strategy, commercialization, go-to-market execution, business development, commercial excellence, organizational performance and practical enterprise AI adoption.
A perspective built across the life sciences ecosystem
Carl's experience spans the companies bringing therapies to patients and the technology, data and service organizations helping them perform. That perspective allows RISE to see the market from both sides: how life sciences enterprises evaluate consequential investments and how innovative partners must establish relevance, trust and a credible path to value.
Founder-led by design
Every RISE engagement includes Carl's direct involvement. He helps frame the real decision, challenge assumptions, align stakeholders and translate strategic choices into an executable path. When a challenge requires additional expertise, RISE assembles a focused team from a trusted network built over decades.
What Carl writes about
Through Curbside Consults™ by RISE, Carl publishes a weekly executive briefing on the forces reshaping life sciences growth, commercialization, customer engagement, enterprise AI and organizational execution.